Cogent Biosciences Announces Additional Clinical Data From Part 1 of Its Ongoing Summit Trial Evaluating Bezuclastinib in Patients With Nonadvanced Systemic Mastocytosis (Nonadvsm)
cogent biosciences宣佈了其正在進行的峯會試驗第一部分中Bezuclastinib評估非晚期全身性肥大細胞增多症（Nonadvsm）患者的額外臨床數據。